These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22451317)

  • 1. Lipid lowering agents, cognitive decline, and dementia: the three-city study.
    Ancelin ML; Carrière I; Barberger-Gateau P; Auriacombe S; Rouaud O; Fourlanos S; Berr C; Dupuy AM; Ritchie K
    J Alzheimers Dis; 2012; 30(3):629-37. PubMed ID: 22451317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-specific associations between lipids and cognitive decline in the elderly.
    Ancelin ML; Ripoche E; Dupuy AM; Samieri C; Rouaud O; Berr C; Carrière I; Ritchie K
    Eur Neuropsychopharmacol; 2014 Jul; 24(7):1056-66. PubMed ID: 24721317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.
    Dufouil C; Richard F; Fiévet N; Dartigues JF; Ritchie K; Tzourio C; Amouyel P; Alpérovitch A
    Neurology; 2005 May; 64(9):1531-8. PubMed ID: 15883313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of statin use with cognitive decline in elderly African Americans.
    Szwast SJ; Hendrie HC; Lane KA; Gao S; Taylor SE; Unverzagt F; Murrell J; Deeg M; Ogunniyi A; Farlow MR; Hall KS
    Neurology; 2007 Nov; 69(19):1873-80. PubMed ID: 17984456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C Study.
    Straczek C; Tafflet M; Barberger-Gateau P; Bertrand M; Dupuy AM; Ducimetière P; Empana JP
    Atherosclerosis; 2011 Feb; 214(2):426-31. PubMed ID: 21129746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study.
    Bettermann K; Arnold AM; Williamson J; Rapp S; Sink K; Toole JF; Carlson MC; Yasar S; Dekosky S; Burke GL
    J Stroke Cerebrovasc Dis; 2012 Aug; 21(6):436-44. PubMed ID: 21236699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and cognitive functioning in the elderly: a population-based study.
    Benito-León J; Louis ED; Vega S; Bermejo-Pareja F
    J Alzheimers Dis; 2010; 21(1):95-102. PubMed ID: 20413854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to a Mediterranean diet, cognitive decline, and risk of dementia.
    Féart C; Samieri C; Rondeau V; Amieva H; Portet F; Dartigues JF; Scarmeas N; Barberger-Gateau P
    JAMA; 2009 Aug; 302(6):638-48. PubMed ID: 19671905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.
    Carrière I; Fourrier-Reglat A; Dartigues JF; Rouaud O; Pasquier F; Ritchie K; Ancelin ML
    Arch Intern Med; 2009 Jul; 169(14):1317-24. PubMed ID: 19636034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid parameters, lipid lowering drugs and the risk of venous thromboembolism.
    Delluc A; Malécot JM; Kerspern H; Nowak E; Carre JL; Mottier D; Le Gal G; Lacut K
    Atherosclerosis; 2012 Jan; 220(1):184-8. PubMed ID: 22035572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a functional polymorphism in the cholesteryl ester transfer protein (CETP) gene with memory decline and incidence of dementia.
    Sanders AE; Wang C; Katz M; Derby CA; Barzilai N; Ozelius L; Lipton RB
    JAMA; 2010 Jan; 303(2):150-8. PubMed ID: 20068209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents.
    Dupuy AM; Carrière I; Scali J; Cristol JP; Ritchie K; Dartigues JF; Gambert P; Ancelin ML
    Climacteric; 2008 Feb; 11(1):74-83. PubMed ID: 18202967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuroprotective effects of caffeine: a prospective population study (the Three City Study).
    Ritchie K; Carrière I; de Mendonca A; Portet F; Dartigues JF; Rouaud O; Barberger-Gateau P; Ancelin ML
    Neurology; 2007 Aug; 69(6):536-45. PubMed ID: 17679672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of dietary cholesterol and egg intakes with the risk of incident dementia or Alzheimer disease: the Kuopio Ischaemic Heart Disease Risk Factor Study.
    Ylilauri MP; Voutilainen S; Lönnroos E; Mursu J; Virtanen HE; Koskinen TT; Salonen JT; Tuomainen TP; Virtanen JK
    Am J Clin Nutr; 2017 Feb; 105(2):476-484. PubMed ID: 28052883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.
    Schilling S; Tzourio C; Soumaré A; Kaffashian S; Dartigues JF; Ancelin ML; Samieri C; Dufouil C; Debette S
    PLoS Med; 2017 Mar; 14(3):e1002265. PubMed ID: 28350817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study.
    Cramer C; Haan MN; Galea S; Langa KM; Kalbfleisch JD
    Neurology; 2008 Jul; 71(5):344-50. PubMed ID: 18663180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study.
    Samaras K; Makkar S; Crawford JD; Kochan NA; Wen W; Draper B; Trollor JN; Brodaty H; Sachdev PS
    Diabetes Care; 2020 Nov; 43(11):2691-2701. PubMed ID: 32967921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Statin Therapy on Cognitive Decline and Incident Dementia in Older Adults.
    Zhou Z; Ryan J; Ernst ME; Zoungas S; Tonkin AM; Woods RL; McNeil JJ; Reid CM; Curtis AJ; Wolfe R; Wrigglesworth J; Shah RC; Storey E; Murray A; Orchard SG; Nelson MR;
    J Am Coll Cardiol; 2021 Jun; 77(25):3145-3156. PubMed ID: 34167639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline.
    Beydoun MA; Boueiz A; Abougergi MS; Kitner-Triolo MH; Beydoun HA; Resnick SM; O'Brien R; Zonderman AB
    Neurobiol Aging; 2012 Apr; 33(4):720-731.e4. PubMed ID: 20619505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between adverse childhood events and later-life cognitive function and dementia risk.
    Nilaweera D; Freak-Poli R; Gurvich C; Ritchie K; Chaudieu I; Ancelin ML; Ryan J
    J Affect Disord; 2022 May; 304():128-132. PubMed ID: 35219735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.